Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Turning wetter and fresher on Sunday
Humid, dry and warm start to the weekend, but turning fresher and wetter on Sunday afternoon
A little boy and his parents were subjected to vile racist slurs by another mum at a primary school end-of-term play, they have claimed.